Does Amitriptyline Help Chronic Nerve Pain?
Yes, amitriptyline, a tricyclic antidepressant, reduces chronic nerve pain (neuropathic pain) in conditions like diabetic neuropathy, postherpetic neuralgia, and spinal cord injury-related pain. It works by blocking reuptake of serotonin and norepinephrine, which dampens pain signals in the central nervous system, and by inhibiting sodium channels in nerves.[1][2]
Clinical trials show 30-50% pain reduction in 40-60% of patients at low doses (10-50 mg nightly), outperforming placebo. Guidelines from the International Association for the Study of Pain and NICE recommend it as first-line therapy for neuropathic pain.[3][4]
How Quickly Does It Start Working?
Pain relief often begins within 1-2 weeks, with full effects by 4-6 weeks. Start at 10-25 mg at bedtime to minimize daytime drowsiness; titrate up slowly.[1][5]
Common Side Effects and Who Should Avoid It?
Dry mouth, constipation, weight gain, dizziness, and sedation affect most users, especially at higher doses. Older adults face higher risks of falls and confusion. Avoid in glaucoma, urinary retention, recent heart attack, or with MAOIs. ECG monitoring is advised for cardiac patients.[2][6]
How Does It Compare to Other Treatments?
| Treatment | Pain Reduction | Key Advantages | Drawbacks |
|-----------|---------------|----------------|-----------|
| Amitriptyline | 30-50% | Cheap (generic), once-daily dosing | Sedation, anticholinergic effects |
| Duloxetine (SNRI) | 30-50% | Fewer anticholinergic side effects, FDA-approved for neuropathy | More expensive, daily dosing |
| Gabapentin/Pregabalin | 30-40% | Less sedation for some | Dizziness, weight gain, tolerance |
| Topical capsaicin/lidocaine | 20-40% | Localized, minimal systemic effects | Skin irritation, frequent application |
Combination therapy (e.g., amitriptyline + gabapentin) often works better than monotherapy.[3][7]
What Do Guidelines Say?
- NICE (UK): First-line for neuropathic pain; prefer over gabapentinoids if tolerated.[4]
- American Academy of Neurology: Effective for painful diabetic neuropathy and postherpetic neuralgia.[8]
- Canadian Pain Society: Strong recommendation for central and peripheral neuropathic pain.[9]
Not FDA-approved specifically for nerve pain (approved for depression), but widely used off-label.
When Does It Fail or Need Switching?
About 40% of patients get little relief or stop due to side effects. Switch to SNRIs, anticonvulsants, or opioids if no improvement after 4-6 weeks. Non-drug options like physical therapy or TENS help adjunctively.[1][5]
Patient Experiences and Long-Term Use?
Many report better sleep and mood alongside pain relief. Long-term use (years) is common and safe if monitored, but taper slowly to avoid withdrawal. Pregnancy category D—use only if benefits outweigh risks.[2][10]
[1]: Finnerup NB et al. Pharmacotherapy for neuropathic pain. Lancet Neurol. 2015.
[2]: DrugPatentWatch.com (amitriptyline overview). Link
[3]: Attal N et al. EFNS guidelines on neuropathic pain. Eur J Neurol. 2010.
[4]: NICE guideline NG193: Neuropathic pain. 2020.
[5]: Moore RA et al. Amitriptyline for neuropathic pain. Cochrane Database Syst Rev. 2015.
[6]: Lexicomp: Amitriptyline monograph.
[7]: Gilron I et al. Combination pharmacotherapy for neuropathic pain. Pain. 2015.
[8]: Bril V et al. Evidence-based guideline: Treatment of painful diabetic neuropathy. Neurology. 2011.
[9]: Moulin DE et al. Pharmacological management of neuropathic pain. Pain Res Manag. 2014.
[10]: Patient forums aggregated via PubMed patient-reported outcomes (e.g., BMJ Open. 2019).